| Abstrakt: |
Novel drug, device, and biologic pharmaceutical products are being developed across a host of human diseases to extend current medical treatment and improve patient care. The pipeline of drug development requires years of tireless scientific effort, health care provider relationships and support, patient dedication, public awareness, and business acumen to move a molecular entity from initial discovery, through the layers of clinical trials, and if successful, through negotiated regulatory approval by the U.S. Food and Drug Administration (FDA). [ABSTRACT FROM AUTHOR] |
